Amendment determination — Conditions (PB 20 of 2010)
as amended
made under paragraph 98C(1)(b) of the
National Health Act 1953
This compilation was prepared on 31 March 2010
taking into account amendments up to PB 32 of 2010
Prepared by the Office of Legislative Drafting and Publishing,
Attorney-General’s Department, Canberra
Amendment determination — Conditions (PB 20 of 2010)
1 Commencement
This instrument commences on 1 April 2010.
2 Amendment of PB 119 of 2008
Schedule 1 amends PB 119 of 2008.
Schedule 1 Amendments
[1] Schedule 4, after item dealing with Cromoglycic Acid
insert in the columns in the order indicated:
Dabigatran etexilate | Capsules 75 mg (as mesilate), 60 Capsules 110 mg (as mesilate), 60 |
[2] Schedule 4, item dealing with Hydrocortisone
omit from the column headed “Form (strength, type, size, etc.)”:
| Cream 10 mg per g, 50 g |
[3] Schedule 4, item dealing with Pilocarpine
omit from the column headed “Form (strength, type, size, etc.)”:
| Eye drops containing pilocarpine hydrochloride 60 mg per mL, 15 mL |
[4] Schedule 4, item dealing with Rivaroxaban
omit all entries from the column headed “Form (strength, type, size, etc.)” and substitute:
| Tablets 10 mg, 15 Tablets 10 mg, 30 Tablets 10 mg, 10 |
Notes to the Amendment determination — Conditions (PB 20 of 2010)
Note 1
The Amendment determination — Contributions (PB 20 of 2010) (in force under paragraph 98C(1)(b) of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.
Table of Instruments
Title | Date of FRLI Registration | Date of | Application, saving or |
PB 20 of 2010 | 17 Mar 2010 (see F2010L00678) | 1 Apr 2010 |
|
PB 32 of 2010 | 30 Mar 2010 (see F2010L00775) | 31 Mar 2010 | — |
Table of Amendments
ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted | |
Provision affected | How affected |
Schedule 1 |
|
Schedule 1............ | am. PB 32 of 2010 |